|
Jul 28
|
Enlivex Reaffirms August 18, 2025 As Target Date For Announcement of Phase II Topline Data
|
|
Jun 13
|
Enlivex Therapeutics and Foremost Clean Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
|
Jun 10
|
Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology
|
|
Feb 18
|
Enlivex Issues Urgent Statement on Fraudulent News Dissemination
|